Cohort study of Chinese medicine Weichangan for strengthening the spleen and gene characteristics analysis on advanced colorectal cancer

Phase 1

• Conditions: Colorectal cancer

• Registration Number: ITMCTR2000003857
• Lead Sponsor: onghua Hospital Shanghai University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) A clear pathological diagnosis is a patient with colorectal cancer;
(2) Have complete TNM staging information;
(3) There is a clear diagnosis of the location and time of metastasis;
(4) Aged >= 18 years and <= 80 years, male or female;
(5) There is a clear time for the first treatment with Chinese medicine;
(6) Patients who can receive long-term follow-up.

Exclusion Criteria

(1) Patients with colorectal cancer diagnosed pathologically as adenosquamous carcinoma, squamous cell carcinoma, carcinoid, small cell carcinoma, malignant lymphoma, etc.;
(2) Patients with double cancer, multiple or metastatic colorectal cancer;
(3) Combined with severe acute and chronic diseases that may affect treatment and prognosis, such as myocardial infarction, stroke, severe renal insufficiency and mental illness.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression Free Survival;

Secondary Outcome Measures

Name	Time	Method
Overall Survival;